Sign Up to Receive the Latest Trading Tips and News from Prosper

    September 18, 2018

    Viking Therapeutics May Have Another Conquest

    We had big movements in two stocks in the biotech/healthcare space. One was Abbvie (ABBV), whose stock was hammered late in the trading session after it was announced that the California Department. Of Insurance is suing the company over alleged kickbacks in the promotion of Humira. Meanwhile, Viking Therapeutics (VKTX) was up dramatically on successfully […]

    Read Article
    September 17, 2018

    New Life For Opko Health

    Opko Health Inc. rose sharply today in trading as the recoup nearly 50% of its losses from September 7th. The stock (Ticker: OPK) slumped sharply this month due to the news that the SEC is investigating an alleged stock price manipulation scheme that affected OPK in addition to other stocks. Numerous class action lawsuits have […]

    Read Article
    September 14, 2018

    Class Action Lawsuit Hamstrings Opko Health Inc.

    Opko Health Inc. was hammered when trading resumed today. The stock was down over 10% when trading resumed today after being halted on September 7th. The reason for the drop is a class action lawsuit against the company on the heels of an SEC complaint of stock price manipulation in the stock. Here’s a recap […]

    Read Article
    September 13, 2018

    There Is Room To the Upside In Biotech

    Today’s trading in biotech and healthcare was rough, once again. However, we did get some long signals for a couple stocks, EVH and FCSC. The later was actually triggered late yesterday but was still active today. Overall, upside potential seems strongest for generic healthcare stocks, but biotech has begun to catch up. Here’s what happened.

    Read Article
    September 11, 2018

    Rough Day For the Biotechs

    Today was rough for biotechs and healthcare stocks. The market was very erratic, with very inconsistent price movement throughout the session. Our open long signals were sharply lower despite the overall bullish trend in the equities markets. A good example of this is CMDO, which rallied sharply off of earnings news, only to decline just […]

    Read Article
    September 10, 2018

    The Move In Amgen Was A Mystery

    Shares of Amgen (AMGN) moved sharply higher today, but the exact reason for the move is unknown. The stock was up over 3% at the time this content was written. Recently, Amgen and AstraZeneca announced a breakthrough therapy designation for Tezepelumab, a treatment they jointly developed for patients with severe asthma. A buy signal was […]

    Read Article
    September 7, 2018

    Was Today’s Market Action Over(ZEAL)ous?

    Zealand Pharma (ZEAL) was up sharply today on news of a deal with Royalty Pharma. Zeal reported it sold royalty streams and milestones to Royalty Pharma for $205M. This news caused ZEAL shares to rise over 15% on the news, but it is questionable if this will result in further upside. Here’s an overview of […]

    Read Article
    September 6, 2018

    Arrowhead Pharmaceuticals Right On Target

    We saw some big moves in the biotech/healthcare space today. One of the biggest movers was Arrowhead Pharmaceuticals (ARWR). The stock moved up over 40% during the peak of the session, reaching a high of $22.39 before gradually pulling back to around $19 per share. The stock was up due to positive results on a […]

    Read Article
    September 4, 2018

    Mannkind Strikes A Deal!

    MannKind (MNKD) moved up sharply today due to an exclusive agreement it signed with United Therapeutics. In the deal, MNKD allows United to be responsible for global development, regulatory and commercial activities for the development and commercialization of a product being developed by MNKD to treat pulmonary arterial hypertension. Here’s a recap of the trade […]

    Read Article